New compounds III

Details for Australian Patent Application No. 2008333110 (hide)

Owner AstraZeneca AB (Publ)

Inventors Higginbottom, Michael; Brown, Giles A.; Boyd, Joseph W.

Agent Davies Collison Cave

Pub. Number AU-A-2008333110

PCT Pub. Number WO2009/071677

Priority 61/022,937 23.01.08 US; 0702698-2 05.12.07 SE

Filing date 5 December 2008

Wipo publication date 11 June 2009

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/071677 Priority application(s): WO2009/071677

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333111-Morpholine derivates as antiobesity agents

2008333108-Method of installing a tubular undersea pipeline